TickerFactsScreenerDevelopers

BridgeBio Pharma, Inc. (BBIO) — Net Income

Annual figures by fiscal year, from SEC filings.

2017: -$43.83M2018: -$169.45M2019: -$288.58M2020: -$505.49M2021: -$586.45M2022: -$484.65M2023: -$653.25M2024: -$543.35M2025: -$732.94M-$732.94M
2017Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$732.94M-34.9%
2024-$543.35M+16.8%
2023-$653.25M-34.8%
2022-$484.65M+17.4%
2021-$586.45M-16.0%
2020-$505.49M-75.2%
2019-$288.58M-70.3%
2018-$169.45M-286.6%
2017-$43.83M—